S 1225: Requires periodic reviews of pending applications for material change in the coverage status of certain matters relative to new health technology assessment or medical evidence.
The bill aims to require periodic reviews of pending applications for material changes in the coverage status of certain health technologies, new medical evidence, or health services. The commissioner must conduct a review within three months of receiving an application and notify the applicant if the application is incomplete. The review must be published on the department's website within seven days of the review date. The commissioner will issue a report to the chair of the standing committee on health within thirty days of the review, detailing the date of application, review date, and determination of sufficiency of evidence. The committee must issue a recommendation within six months of the determination. The committee will consider material changes in coverage status and new medical evidence, and the commissioner must provide the committee with evidence and information related to…
| Mar. 05, 2026 | referred to health |
| Mar. 05, 2026 | DELIVERED TO ASSEMBLY |
| Mar. 05, 2026 | PASSED SENATE |
| Feb. 11, 2026 | ADVANCED TO THIRD READING |
| Feb. 10, 2026 | 2ND REPORT CAL. |
STATE OF NEW YORK ________________________________________________________________________ 1225 2025-2026 Regular Sessions IN SENATE January 8, 2025 ___________ Introduced by Sens. RIVERA, RAMOS -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the social services law, in relation to requiring peri- odic reviews of pending applications for material change in the cover- age status of certain matters relative to new health technology assessment or medical evidence The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 5 of section 365-d of the social services law, 2 as added by section 46-a of part B of chapter 57 of the laws of 2015, is 3 amended to read as follows: 4 5. (a) The commissioner, in consultation with the committee, shall 5 undertake periodic reviews of pending applications for material change 6 in the coverage status of a particular item, health technology or 7 service, and any matter relative to new health technology assessment or 8 medical evidence for which an applicant has submitted a complete appli- 9 cation to the department within three months of receipt. The department 10 shall notify an applicant of incompleteness within thirty days of 11 receipt of submission. Receipt of applications shall be published on the 12 department's website within seven days of receipt. The commissioner 13 shall schedule a review of such pending applications and cause publica- 14 tion of the date of review on the department's website within seven days 15 of the review required by this paragraph. 16 (b) The commissioner, in consultation with the committee, shall issue 17 a report to the chair of the standing committee on health in the senate 18 and assembly and publish the report on the department's website within 19 thirty days of review of any pending application pursuant to paragraph 20 (a) of this subdivision. Such report shall provide the date of applica- 21 tion, date of review, and a stated determination of sufficiency of 22 evidence warranting committee deliberation and recommendation. In the 23 event of an affirmative determination of sufficiency of evidence, the EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD03478-01-5S. 1225 2 1 commissioner shall require the committee to issue a recommendation with- 2 in six months of such determination of sufficiency. In the event of a 3 negative determination, the commissioner shall detail such insufficiency 4 of evidence and allow the applicant to cure stated deficiencies for 5 review under the requirements provided in paragraph (a) of this subdivi- 6 sion. 7 (c) The committee shall consider any matter regarding material changes 8 in the coverage status of a particular item, health technology or 9 service, and any matter relative to new health technology assessment or 10 medical evidence review for which the department determines a sufficient 11 body of evidence exists to warrant committee deliberation. The commis- 12 sioner shall provide members of the committee with any evidence or 13 information related to the health technology or medical service assess- 14 ment including but not limited to, information submitted by members of 15 the public. The department shall report to the committee programmatic 16 changes to benefits that do not rise to the level of a material change, 17 as well as determinations of when sufficient medical evidence exists to 18 warrant committee deliberations. The commissioner shall provide forty- 19 five days public notice on the department's website prior to any meeting 20 of the committee to develop recommendations concerning health technology 21 or medical service coverage determinations. Such notice shall include a 22 description of the proposed health technology or service to be reviewed, 23 the conditions or diseases impacted by the health technology or service, 24 the proposals to be considered by the committee, and the systematic 25 evidence-based assessment prepared in accordance with this subdivision. 26 The committee shall allow interested parties a reasonable opportunity to 27 make an oral presentation to the committee related to the health tech- 28 nology or service to be reviewed and to submit written information. The 29 committee shall consider any information provided by any interested 30 party, including, but not limited to, health care providers, health care 31 facilities, patients, consumers and manufacturers. For all health tech- 32 nologies or services selected for review, the department shall conduct 33 or commission a systematic evidence-based assessment of the health tech- 34 nology's or service's safety and clinical efficacy. The assessment shall 35 use established systematic review elements, study quality assessment, 36 and data synthesis. Upon completion, the systematic, evidence-based 37 assessment shall be made available to the public. 38 § 2. This act shall take effect immediately.